MedGenome - About the company
MedGenome is a series E company based in Bengaluru (India), founded in 2013 by Sreedhar Santhosh and Mahesh Pratapneni. It operates as a Provider of DNA sequencing, bioinformatics, and multiomics services. MedGenome has raised $264M in funding from investors like Peak XV Partners, Novo Holdings and HDFC, with a current valuation of $*****. The company has 81 active competitors, including 6 funded and 6 that have exited. Its top competitors include companies like Metropolis India, CORE and Lilac Insights.
Company Details
Provider of DNA sequencing, bioinformatics, and multiomics services. It offers a comprehensive suite of genomic services which include whole genome and exome sequencing, single-cell sequencing, spatial transcriptomics, and immune profiling. It also provides robust bioinformatics support, including analysis pipelines and data visualization tools, to facilitate research and drug discovery. The services are tailored to support research in various areas, including rare disease research, cancer research, and antibody discovery.
- Website
- medgenome.com
- Registered Address
- Sy. Nos. 94/1C and 94/2, Tower 1, Ground Floor, Veerasandra Village, Attibele Hobli, Electronic City Phase-1, Electronics City, Bangalore, Bangalore South, Karnataka, India, 560100
Key Metrics
Founded Year
2013
Location
Bengaluru, India
Stage
Series E
Total Funding
$264M in 10 rounds
Latest Funding Round
Post Money Valuation
$***** as on Dec 18, 2021
Investors
Ranked
1st among 81 active competitors
Annual Revenue
₹100 - ₹500 Cr as on Mar 31, 2025
Employee Count
922 as on May 31, 2025
Similar Companies
Legal entities associated with MedGenome
MedGenome is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
MEDGENOME INC CIN: 32076340333 , United States, Active | - | - | - | |
MEDGENOME LABS LIMITED CIN: U73100KA2013PLC084414 , India, Active | Apr 08, 2013 | ₹100 - ₹500 Cr (As on Mar 31, 2025) | 1032 (As on May 01, 2026) |
Sign up to download MedGenome's company profile
MedGenome's funding and investors
MedGenome has raised a total funding of $264M over 10 rounds. Its first funding round was on Aug 20, 2013. Its latest funding round was a Series E round on Jul 21, 2025 for $*****. 3 investors participated in its latest round. MedGenome has 21 institutional investors and 11 angel investors.
Here is the list of recent funding rounds of MedGenome:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 21, 2025 | 6150887 | Series E | 7478122 | 1813979 | 8293806 | 8746817 |
Aug 30, 2022 | 9811837 | Series D | 7726661 | 9211738 | 3442365 | |
Jul 15, 2021 | 3636971 | Series D | 2587761 | 4411619 |
View details of MedGenome's funding rounds and investors
MedGenome's founders and board of directors
Founder? Claim ProfileThe founders of MedGenome are Sreedhar Santhosh and Mahesh Pratapneni. Mahesh Pratapneni, Felix Olale and Vedam Ramprasad are the CEOs of MedGenome.
Here are the details of MedGenome's key team members:
- Sreedhar Santhosh: Co-Founder of MedGenome and founder of 1 other company. They are also an angel investor in 1 startup and serve on the board of 1 company.
- Mahesh Pratapneni: Co-Founder and Group CEO of MedGenome and founder of 2 other companies, Emerge Ventures and Genomeasia100K. Contact Info: 1 email address and 1 phone number
- Vedam Ramprasad: CEO of MedGenome. Contact Info: 1 email address
MedGenome's Board of Directors
MedGenome's board has 4 active members. Mahesh Pratapneni is part of team and Navjeewan Jatinder Khosla, Prasad Bhagwan Shejale and Shankar Mahadevappa Prasad are independent board members.Here is the list of MedGenome's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 7y 1m | |
Independent board member | - | Current | 2y 0m | |
viaiyua | Independent board member | - | Current | 9y 7m |
bcudemv | Independent board member | - | Current | 4y 2m |
View details of MedGenome's Founder profiles and Board Members
MedGenome's employee count trend
MedGenome has 922 employees as of May 25. The total employee count is 5.0% more than what it was in May 24. Here is MedGenome's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
MedGenome's Competitors and alternates
Top competitors of MedGenome include Metropolis India, CORE and Lilac Insights. Here is the list of Top 10 competitors of MedGenome, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Provider of DNA sequencing, bioinformatics, and multiomics services | $264M | 70/100 | ||
2nd | Metropolis India 1981, Mumbai (India), Public | Chain of diagnostic centers | $11.7M | 69/100 | |
3rd | Laboratory offering biomarker analysis | $17.3M | 52/100 | ||
4th | Lilac Insights 2011, Mumbai (India), Series A | Provider of genetic diagnostic advisory services for infant | $11M | 52/100 | |
5th | Sterling Accuris Diagnostics 2015, Ahmedabad (India), Series C | Chain of pathology labs | $41.7M | 51/100 | |
6th | Dr Dangs Lab 1983, Delhi (India), Unfunded | Provider of diagnostic testing services in various medical specialties | - | - | 50/100 |
7th | CRL Diagnostics 2015, Delhi (India), Unfunded | Chain of pathology laboratory services | - | - | 49/100 |
8th | Developer of prognostic tests for the detection of cancer | $9M | 45/100 | ||
9th | Rivaara Labs 2019, Mumbai (India), Series A | Provider of molecular diagnostic test lab | $9.89M | 43/100 | |
10th | Accuprobe Diagnostics 2015, Delhi (India), Funding Raised | Provider of pathology testing services at home | - | 39/100 |
Looking for more details on MedGenome's competitors? Click here to see the top ones
Financials of MedGenomeFY 25 Available
MEDGENOME LABS LIMITED, the legal entity associated with MedGenome, generated between ₹100 Cr and ₹500 Cr in revenue for the financial year ending on Mar 31, 2025. The revenue of MEDGENOME LABS LIMITED has a compounded annual growth rate (CAGR) of 36% in the last 1 year.
Financial Statement Summary
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Income Statement | |||||
Revenue | 9849 | 6385 | 6995 | 8350 | 9776 |
Total Sales | 1166 | 9018 | 3976 | 9277 | 7554 |
Total Expenses | 6533 | 2561 | 9901 | 3970 | 4609 |
Operating Expenses | 4530 | 6333 | 6926 | 8224 | 5917 |
Employee Expenses | 3093 | 5721 | 2667 | 2259 | 6005 |
Marketing Expenses | 1839 | 2343 | 9150 | 6113 | 3915 |
Operating Income (EBIT) | 4617 | 2676 | 1045 | 1273 | 6653 |
Interest Expenses | 6437 | 5834 | 3726 | 2452 | 5793 |
Expenses from other activities | 9652 | 1569 | 2461 | 5218 | 2691 |
EBITDA | 8682 | 1138 | 8787 | 2865 | 2246 |
Taxes | 4846 | 3307 | 9379 | 4139 | 8865 |
Net Profit | 8746 | 6016 | 1147 | 5190 | 7796 |
Balance Sheet | |||||
Assets | 7164 | 3961 | 6542 | 7176 | 9476 |
Cash Equivalent | 5100 | 9456 | 7332 | 9185 | 4562 |
Accounts Receivables | 3197 | 3031 | 6786 | 8004 | 2992 |
Inventory | 5588 | 8709 | 7700 | 4171 | 4864 |
Liabilities | 2940 | 8654 | 6522 | 9238 | 3174 |
Total Debt | 3094 | 9373 | 5598 | 2447 | 9929 |
Accounts Payable | 3330 | 6266 | 7692 | 1805 | 6597 |
Equities | 7281 | 6173 | 8756 | 6799 | 9143 |
Cashflow Statement | |||||
Cash from Operating activities | 6642 | 7835 | 4728 | 1665 | 5552 |
Cash from Investing activities | 9786 | 6186 | 9500 | 4772 | 6005 |
Net cash from Financing activities | 9071 | 6249 | 9656 | 5391 | 7762 |
Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)
MedGenome's Investments and acquisitions
MedGenome has not made any investments yet. MedGenome has made 6 acquisitions.Here is the list of latest three $acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
May 18, 2026 | Acquisition | - | ||
Mar 02, 2026 | Acquisition | 2006 | Navi Mumbai (India) | |
Nov 04, 2025 | Acquisition | - |
See all acquisitions by MedGenome
Reports related to MedGenome
Here is the latest report on MedGenome's sector:
News related to MedGenome
Media has covered MedGenome for a total of 6 events in the last 1 year, 2 of them have been about company updates.
•
MedGenome Acquires Majority Stake in Siddhi Diagnostics to Expand Diagnostics ReachVCCircle•May 18, 2026•MedGenome, SDRC
•
MedGenome unveils study indicating clinical impact of RNA-based NGS in sarcoma diagnosisPharmabiz.com•Apr 07, 2026•MedGenome
•
MedGenome Makes a Majority Investment in Medcare DiagnosticsIndiaMedToday•Mar 02, 2026•MedGenome, Medcare Diagnostics
•
•
MedGenome Invests in Green Cross to Expand Genomics Offerings in IndiaBusinessFortNight•Nov 04, 2025•Greencrosslab, MedGenome
•
Shardul Amarchand Mangaldas & Co. Advised Novo Holdings A/S on Investment in MedGenome Inc.Lexology•Sep 26, 2025•Shardul Amarchand Mangaldas, Argus Partners, Sofina, MedGenome and 2 others
•
India’s pharma funding reaches $294 million in July 2025Express Pharma•Aug 04, 2025•MedGenome, Truemeds, SAI Parenterals, Pristyn Care and 4 others
•
MedGenome secures $47.5 million in Series E funding to expand genomic solutions.NewsDrum•Jul 21, 2025•MedGenome, Maj Invest, Novo Holdings, Sofina
•
MedGenome secures $47.5M Series E to expand genomic diagnosticsExpress Healthcare•Jul 21, 2025•MedGenome, Maj Invest, Novo Holdings, Sofina
•
Are you a Founder ?
FAQs about MedGenome
Explore our recently published companies
- Inovant Solutions - India based, 2011 founded, Unfunded company
- Infinity StoneX - Visakhapatnam based, Unfunded company
- Southwest Custom Build - Albuquerque based, 2008 founded, Unfunded company
- Grow&Bless Digital - Jakarta based, 2020 founded, Unfunded company
- Eshwar Venugopal - 2013 founded, Unfunded company
- KIWI Agency - Miami based, 2017 founded, Unfunded company

